Chin, Ik Shin http://orcid.org/0000-0002-7659-8753
Khan, Aman http://orcid.org/0000-0003-2760-1490
Olsson-Brown, Anna
Papa, Sophie http://orcid.org/0000-0002-9063-7675
Middleton, Gary
Palles, Claire http://orcid.org/0000-0002-9670-2263
Funding for this research was provided by:
Cancer Research UK (C11497/A28789)
Article History
Received: 1 September 2022
Accepted: 7 December 2022
First Online: 24 December 2022
Competing interests
: S.P. declares honoraria from BMS, MSD, Roche, Amgen, Remedy Bio, Zelluna, GSK. A.O.-B. received grant support from Roche, Bristol-Myers Squibb, Eli Lily, Novartis, and UCB Pharma, and personal fees from Roche and Bristol-Myers Squibb, all outside the submitted work. G.M. declares honoraria from AZ and Pfizer. All other authors declare no competing interests.